Ronald P. Landbloom
Plus aucun poste en cours
Profil
Ronald P.
Landbloom worked as an Associate Medical Director-Neuroscience at Eli Lilly & Co. from 2005 to 2006.
He then worked as Vice President-Medical & Regulatory Affairs at Orexigen Therapeutics, Inc. from 2006 to 2009.
Landbloom holds a doctorate degree from the University of Minnesota and an undergraduate degree from The University of New Mexico.
Anciens postes connus de Ronald P. Landbloom
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/10/2006 |
| OREXIGEN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Ronald P. Landbloom
| The University of New Mexico | Undergraduate Degree |
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
